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Summary
Background. — Arterial stiffness is a strong predictor of cardiovascular events and particularly
of stroke. A likely explanation is the development of atherosclerotic lesions at the carotid level,
favored by increased local stiffness. Another possibility involves cardiac consequences of aortic
stiffness and particularly left atrial dilatation with its subsequent risk of atrial fibrillation (AF)
and cerebral embolism. 
Aims. — The present study investigated the link between arterial stiffness, pulse pressure and
left atrial size, a determinant of AF risk. 
Methods. — Arterial stiffness was determined from pulse wave velocity (PWV) and pulse
pressure (PP). Left atrial size was also measured. Several potential confounders were taken into
account including indices of ventricular remodeling and diastolic function (estimated by NT-Pro
brain natriuretic peptide (NT-proBNP) levels). 
Results. — Three-hundred and ten hypertensive patients, aged 53 ± 13 years, were included.
Mean 24-h blood pressure (BP) was 154 ± 20 over 93 ± 13 mmHg. Significant relationships were
found between left atrial diameter (LAD) and PWV (r=0.27, P<0.001) and between LAD and 24-
h PP (r=0.32, P<0.001). LAD was also correlated significantly, although not always tightly, with
left ventricular dimensions, geometry and NT-proBNP. In two different multivariate models,
LAD remained significantly correlated with PWV or with 24-h PP, independently of classical
determinants like age, gender, body mass index, ventricular remodeling (i.e. dimensions and
geometry) and filling pressure. 
Conclusion. — These results led us to propose AF as a new possible pathophysiological link
between arterial stiffness and stroke. These results also emphasize the cardiac consequences
of arterial stiffness which can fuel a new approach to AF prevention.
© 2008 Published by Elsevier Masson SAS.
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Résumé
Justification. — La rigidité artérielle est un prédicteur puissant d’évènements cardio-
vasculaires et notamment d’accidents vasculaires cérébraux (AVC). Ce rôle pronostique
s’explique probablement par l’influence de la rigidité artérielle sur le développement de
plaques d’athérome carotidiennes. Il pourrait aussi s’expliquer par l’effet de la rigidité
aortique sur le cœur et en particulier sur l’oreillette gauche (OG) entraînant un risque accru
de fibrillation atriale (FA) et d’embolies cérébrales. 
Objectifs. Evaluer la relation entre la rigidité artérielle, la pression pulsée (PP) et la taille de l’OG.
Méthodes. — Dans ce travail, un lien entre la rigidité artérielle estimée par la vitesse de l’onde
de pouls (VOP) et la pression pulsée (PP) et la taille de l’OG a été recherché. Les facteurs
confondants potentiels tels que le remodelage cardiaque et la fonction diastolique (estimé par
le taux de NT-Pro brain natriuretic peptide (NT-proBNP)) ont été pris en compte. 
Résultats. — Trois cent dix hypertendus âgés de 53 ± 13 ans ont été inclus. Leur pression
moyenne des 24 heures était de 154 ± 20 / 93 ± 13 mm Hg. L’OG était significativement corrélée
à la VOP (r=0,27, P<0,001) et à la PP (r=0,32, P<0,001). Le diamètre de l’OG était aussi
significativement corrélé aux dimensions et à la géométrie du ventricule gauche ainsi qu’au NT-
proBNP. Dans deux modèles multivariés, les indices de rigidité (VOP et PP) sont restés des
déterminants indépendants du diamètre de l’OG après ajustement sur les facteurs confondants
suivants: age, genre, indice de masse corporelle, remodelage cardiaque (dimensions et
géométrie), pressions de remplissage. 
Conclusion. — Nos résultats suggèrent que l’association de la rigidité aortique avec le risque
d’AVC pourrait être lié une augmentation du risque de FA. Les conséquences cardiaques de la
rigidité aortique permettent d’envisager de nouvelles pistes pour la prévention de la FA. 
© 2008 Published by Elsevier Masson SAS.
Introduction
Arterial stiffness is a strong independent predictive factor
for stroke (1) and is associated with cognitive impairment in
the elderly (2). Arterial stiffness involves collagen deposi-
tion, fragmentation of elastic tissue and calcifications. It is
affected by the amount and density of stiff wall material
and the spatial organization of that material (3). Aortic
stiffening and the subsequent increase in central pulse
pressure (PP) are associated with carotid intima-media
thickening (4), atheroma formation (5) and plaque rupture
(6). These "local" effects are likely to play a crucial role in
the pathophysiology of stroke. 
Aortic stiffness also exerts an effect on left ventricular
geometry and diastolic function (7). When considering a
more advanced stage of heart disease, arterial stiffening
increases the risk of heart failure, emphasizing the inter-
play between vascular mechanics and heart function (8).
Because ventricular remodeling is a powerful determinant
of left atrial size (9), it is conceivable that arterial stiffness
influences left atrial diameter (LAD). Atrial fibrillation (AF),
which is closely related to atrial size (10), would then be a
potential link between aortic stiffness and stroke. 
The aim of the present study was to determine the rela-
tionship between arterial stiffness and LAD, independently
of important confounders such as left ventricular remodel-
ing and diastolic function. Left ventricular remodeling was
assessed from ventricular dimensions [left ventricular diam-
eter (LVD) and left posterior wall thickness (LPWT)] and
geometry (relative wall thickness). NT-Pro brain natriuretic
peptide (NT-pro BNP) was used as a surrogate marker of fill-
ing pressure and diastolic function (11). We took into
account not only aortic stiffness but also PP, which is influ-
enced by arterial stiffness. 
Methods
Three-hundred and sixty-eight consecutive hypertensive
patients referred to our cardiology department (Hôpital de
la Croix-Rousse, Lyon) for clinical work-up were assessed
and 310 of these who had an available LAD determination
were included in the study. Patients maintained their usual
sodium regimens before and during hospitalization. When-
ever possible, any ongoing antihypertensive therapy was
discontinued 2 weeks before admission (6 weeks for
spironolactone) for hormone measurement purposes. If
treatment was deemed mandatory, calcium-channel block-
ers or central agents were used in most cases. Twenty-four
hour blood pressure (24-h BP) measurements and blood col-
lections after overnight recumbency were performed. Stan-
dard biological testing included serum creatinine, urinary
microalbumin or protein, electrolytes and creatinine. Crea-
tinine clearance was estimated using the Cockcroft formula
and expressed as ml/min. 
Ambulatory blood pressure recordings
24-h BP recordings were obtained using Diasys (model 200
RS; Novacor) or Spacelabs (model 90207; Spacelabs) moni-
tors that satisfied the criteria of the British Hypertension
Society and the Association for the Advancement of Medical
Instrumentation (12). Twenty-four hour systolic pressure
(SBP), diastolic pressure (DBP) and PP were recorded at 15
min intervals during the day and at 30 min intervals during
the night. 
Pulse wave velocity measurement
Pulse wave velocity (PWV) measurements were obtained
using a Complior device (Complior; Colson, Garges-les-
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Gonesse, France) following a procedure described previ-
ously (13). This device has been validated and provides an
accurate automatic measurement of PWV (14). Briefly,
two transducers were placed at the base of the neck for
the common carotid artery and over the femoral artery.
The two transducers were positioned so as to record the
best signals. The quality of the carotid and femoral pulse
waves was checked visually and 25 pulse waves were
recorded and stored. The transit time between the carotid
and femoral pulse waves was determined automatically by
the software. The distance between the two recording
sites was measured, allowing PWV to be calculated as the
ratio of the distance to the transit time. The 25 measure-
ments were averaged to provide PWV for one given
patient.
Echocardiography
M-mode echocardiograms were recorded with a commer-
cially available echocardiograph (Vingmed System Five and
VIVID Five; General Electric) with the patient lying in left
lateral position (15). The transducer was placed in the third
or fourth intercostal space. Two-dimensional mode exami-
nation allowed selection of the best parasternal line. LAD,
LVD, and LPWT were measured. A reliable interventricular
septum thickness was obtained less frequently precluding
left ventricular mass calculation. LVD and LPWT were used
as indicators of ventricular mass. Relative wall thickness
(RWT = 2 x LPWT/LVD) was calculated and provided an esti-
mation of left ventricular geometry, also known to
influence LAD (9).
NT-Pro brain natriuretic peptide measurement
Plasma NT-proBNP was measured by electrochemilumines-
cence using an Elecsys 2010 NT-proBNP assay (Roche Diag-
nostics) according to manufacturer's instructions. The range
of values was 5-35000 pg/ml and the coefficient of variation
was between 1 and 2.5%.
Statistical analysis
Values are expressed as means ± SD. Because of their
skewed distribution, the natural logarithms of PWV and NT-
proBNP were used for statistical tests. Statistical analysis
was performed with the Statistica 5.1 software package
(Statsoft Inc, Tulsa). Associations between variables were
tested by univariate regression (Pearson’s coefficient of
correlation ”r”) and by forward stepwise multiple linear
regression analysis with mean substitution in the case of
missing variables. Multivariate analyses were restricted to
those patients with an available stiffness marker (i.e. PWV
or 24-h PP, depending on that used in the model). A P value
<0.05 was considered significant. 
Results
Characteristics of the overall population 
The demographic characteristics of the whole group are
shown in Table 1. Mean age was 53 ± 13 years, 166 were male,
and the majority (75%) received anti-hypertensive treatment.
24-h BP was 154 ± 20 and 93 ± 13 mmHg for SBP and DBP, res-
pectively, for the whole group. LAD was 39 ± 6 mm. Arterial
PWV was 12 ± 3 m/s and 24-h PP was 62 ± 14 mmHg.
Correlates between atrial size, ventricular
remodeling and arterial stiffness in univariate
analysis
LAD was significantly associated with age (r=0.23, P<0.001),
24-h SBP (r=0.22, P<001), body mass index (r=0.44,
P<0.001) and creatinine clearance (r=0.14, P<0.05), but not
with 24-h DBP. LAD was significantly larger in men than in
women (P<0.001) and in treated vs. untreated subjects
(P<0.001). As shown in Fig. 1, LAD was correlated with indi-
ces of left ventricular mass (LVD, LPWT), and was also cor-
related significantly, although not tightly, with left ventric-
ular geometry (r=0.15, P<0.05) between LAD and RWT.
Finally, atrial size was slightly dependent on filling pressure
(r=0.12, P<0.05 between LAD and NT-proBNP expressed as
its logarithm). 
Both PWV and 24-h PP were correlated with LAD
(Figure 1). Some indices of ventricular remodeling (LPWT
and RWT) were correlated with PWV (r=0.25, P<0.001;
r=0.23, P<0.01, respectively) while LVD was not. Similar
findings were obtained with 24-h PP (r=0.32, P<0.001
between LPWT and 24-h PP; r=0.26, P<0.001 between RWT
and 24-h PP; no significant relationship between LVD and
24-h PP).
Independent relationships between arterial
stiffness and LAD
Because of potential confounders, the relationships
between LAD and arterial stiffness were also studied in mul-
tivariate analyses including all variables significantly asso-
ciated with LAD in a univariate mode as independent fac-
tors. Table 2 shows that LAD remained significantly
Tableau 1 Demographic characteristics of study subjects
Number Values
Age(years) 310 53 ±13
Male/female (n) 310 166/144
Treatment(yes/no) 310 233/77
24-h systolic blood pressure 
(mmHg)
297 154 ± 20
24-hdiastolic blood pressure 
(mmHg)
297 93 ±13
Body mass index(kg/m2) 309 27 ± 5
Creatinine clearance (ml/min) 303 94 ± 34
Let atrial diameter (mm) 310 39 ± 6
Left ventricular diameter (mm) 250 50 ± 5
Relative wall thickness 238 0.43 ± 0.11
Left posterior wall thickness (mm) 241 11 ± 2
Nt-Pro brain natriuretic peptide 
(pg/ml)
310 253 ± 977
24-h pulse pressure (mmHg) 297 62 ± 14
Pulse wave velocity (m/s) 237 12 ± 3
Values for continuous variables are means ± SD. 
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correlated with PWV (used here as a Log value, P<0.05)
independently of usual determinants such as age, gender,
body mass index, ventricular remodeling (i.e. dimensions
and geometry) and filling pressure. Similarly, Table 3 shows
that LAD remained correlated with 24-h PP (P<0.05) inde-
pendently of these determinants. 
Discussion
Our results show that arterial stiffness and subsequent PP
are significantly correlated with atrial size, even after
adjustment for major confounders including left ventricular
remodeling and filling pressure. This suggests that arterial
stiffness per se may contribute to left atrium enlargement
and thus, to the risk of AF and stroke.
Cerebrovascular diseases represent a major health
problem. In the USA, 700 000 people suffer a stroke
annually, a disease known for its high rate of mortality
and disability (16). Stroke risk is highly dependent on BP
(17) but also on arterial stiffness (1). Aortic stiffening
and the subsequent increase in central PP are associated
with carotid intima-media thickening (4), atheroma for-
mation (5) and plaque rupture (6), providing a pathophy-
siological link between vascular mechanics and cerebro-
vascular events.
However, arterial stiffness also influences cardiac
remodeling. Indeed, carotid stiffness is an independent
determinant of left ventricular remodeling (18). In addi-
tion, aortic stiffness has a major impact on diastolic func-
tion (7). In this respect, our study confirms the relationship
between parameters of left ventricular remodeling (LVD,
LPWT and RWT) and arterial stiffness. NT-proBNP, used as a
surrogate marker of diastolic dysfunction (11, 19), was also
correlated with arterial stiffness, a finding in line with pre-
vious reports (7). Because of the close interplay between
left atria, left ventricular remodeling (9) and diastolic func-
tion (20), the relationship between arterial stiffness and
LAD is not surprising. It is further supported by the capacity
of an ACE-inhibitor to improve left atrial structural remod-
eling and vascular compliance in parallel (21).
Nevertheless, as an independent relationship it provides
a potential link between stiffness and AF, which represents
another mechanism of stroke. Indeed, a rather extensive
adjustment was performed to determine that aortic stiff-
ness was independently associated with LAD. This included,
as adjustment variables, left ventricular diameter, poste-
rior wall thickness, relative wall thickness (because of its
important role in atrial remodeling (9)) and NT-proBNP (as
a surrogate marker of filling pressure), in addition to other
confounders (age, body mass index, etc). 
Some limitations to this study should be discussed. First,
we may not have adjusted for all confounders and espe-
cially for systolic function. However, ventricular geometry
has a greater effect on LAD than left ventricular end-sys-
tolic stress (9). Second, we did not use Doppler indices of
diastolic function. The use of NT-proBNP was appropriate
though, since its performance to detect diastolic dysfunc-
tion is as good as that of tissue Doppler imaging (11); in
addition, used as a continuous variable, it is probably more
powerful for statistical testing than the categorical defini-
tion in 3 or 4 stages of diastolic function based on Doppler
estimates. Third, we did not directly address the issue of a
Figure 1. Relationship between left atrial diameter, ventricular
remodeling and different parameters of arterial stiffness.
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link between stiffness and AF and rather used LAD as a sur-
rogate marker of the risk of AF (10). In this regard, the lit-
erature is pretty scant and controversial. Reiffel et al. (22)
did not report any association between arterial stiffness
and AF in a small group of hypertensive and normotensive
subjects. On the other hand, several recent therapeutic tri-
als have shown that treatments reducing arterial stiffness
(23, 24) prevent the occurrence of AF both in hypertensives
(25) and in heart failure patients (26).
Finally, we used brachial PP and not central PP. Periph-
eral PP, most often measured at the site of the brachial
artery, does not fully reflect central PP, measured at the
carotid site. Indeed, in peripheral arteries, reflection sites
are closer than in central arteries, and reflected waves
travel faster on peripheral arteries than on central arteries,
which are less stiff in young subjects. Thus, according to
the “amplification phenomenon”, the amplitude of the
pressure wave is higher in peripheral arteries than in cen-
tral arteries, and brachial PP overestimates central PP in
young subjects. However, these discrepancies are probably
attenuated in our study patients, who had an average age of
53 years. 
One issue which is left open is the mechanism by which
stiffness could directly influence atrial remodeling, bypass-
ing the “ventricular effect”. This question is largely a mat-
ter of speculation and requires caution because of the limi-
tations highlighted above. There is, however, a rapidly
growing number of papers in the literature on the participa-
tion of genes, particularly those involved in matrix pro-
teins, in the thickening process (27). For example, Medley
et al. (28) showed that matrix metalloproteinases are
potential candidates to explain arterial wall remodeling,
especially MMP3 and MMP9 genes. Interestingly, Nakano et
al. (29) found a similar role for one of these genes (MMP9)
as a candidate for atrial remodeling during AF. Other genes
involved in cell-matrix connections, like integrins, provide
additional examples, being activated during vascular and
atrial remodeling (3, 30). In light of these findings, one
might speculate that, for some reason and maybe simply
because of age, similar genes are up-regulated both in the
atria and vessel wall, contributing to a concomitant remod-
eling of both, possibly on top of mechanical effects.
Inflammation may also be involved since it has been
shown that arterial stiffness was related to an increased
level of C-reactive protein as well as of other markers like
IL-6 and TNFα (23, 32). Stiffening at the vascular level may
trigger an inflammatory process, a condition associated
with a greater occurrence of AF (32).
In conclusion, these results provide a new possible patho-
physiological link between arterial stiffness and stroke, and
consequently may open the way for a new approach to AF
prevention. This concept has recently been illustrated by
the LIFE trial, which showed that the drug regimen produc-
ing the most important decrease in left atrial size had the
greatest effect at preventing AF (33).
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